{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:10Z","timestamp":1792788490605,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Key Medical Science and Technology Development Projects of Nanjing Commission of Health","award":["ZKX17034"],"award-info":[{"award-number":["ZKX17034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Crohn\u2019s fistula-in-ano is a refractory disease in colorectal and anal surgery. Although autologous adipose-derived stem cell (ADSC) has been used in the treatment of Crohn\u2019s fistula-in-ano because of its convenience, non-incision of normal tissue, good tolerance, repeatability, quick recovery, less pain, less damage to anal function, and high quality of life during the perioperative period, there are no reports of its use in China. This is the first clinical trial in China on the treatment of Crohn\u2019s fistula-in-ano with ADSC to evaluate its efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 22 patients with Crohn\u2019s fistula-in-ano were enrolled in this study from January 2018 to October 2018 in the Colorectal Disease Center of Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine. Patients were divided (1:1) into an observation group (ADSC) and a control group (incision-thread-drawing procedure). Primary efficacy endpoint evaluated at months 3, 6, and 12 was the closure of fistulas (closure of all treated fistulas at baseline, confirmed by doctor\u2019s clinical assessment and magnetic resonance imaging or transrectal ultrasonography). The patients additionally completed some scoring scales at each follow-up including simplified Crohn\u2019s Disease Activity Index (CDAI), Perianal Disease Activity Index (PDAI), Inflammatory Bowel Disease Questionnaire (IBDQ), pain scores with visual analog score (VAS), and Wexner score. The data of inflammatory indexes were also collected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The healing rates of the observation group and the control group at months 3, 6, and 12 were as follows: 10\/11(90.9%) vs 5\/11(45.5%), 8\/11(72.7%) vs 6\/11(54.5%), and 7\/11(63.6%) vs 6\/11(54.5%), respectively. There was no statistical difference between the two groups. In addition, the improvement in simplified CDAI, PDAI, IBDQ, VAS, and Wexner score of the observation group were better than that of the control group at each follow-up. The inflammatory indexes decreased in both the observation group and the control group at 3 months follow-up. And there were no significant differences in the changes of inflammatory indexes between two groups at month 3 compared with the baseline. Safety was maintained throughout month 12, and adverse events occurred in 63.6% of patients in the observation group and 100% patients in the control group. And no adverse event associated with ADSC injection was observed in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ADSC is a feasible and effective treatment for Crohn\u2019s fistula-in-ano, compared with traditional incision and thread-drawing. It can protect anal function of patients, relieve pain, allow quick recovery, be well-tolerated, and improve the quality of life during perioperative period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>China Clinical Trials Registry, No. ChiCTR1800014599. Registered 23 January 2018.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01636-4","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T09:02:47Z","timestamp":1584435767000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Autologous adipose-derived stem cells for the treatment of Crohn\u2019s fistula-in-ano: an open-label, controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Chungen","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dachao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"key":"1636_CR1","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.cgh.2019.02.043","volume":"17","author":"R Panaccione","year":"2019","unstructured":"Panaccione R, Steinhart AH, Bressler B, et al. Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease. Clin Gastroenterol Hepatol. 2019;17:1680\u2013713. https:\/\/doi.org\/10.1016\/j.cgh.2019.02.043.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"1636_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ajg.2018.27","volume":"113","author":"GR Lichtenstein","year":"2018","unstructured":"Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn\u2019s disease in adults. Am J Gastroenterol. 2018;113:481\u2013517. https:\/\/doi.org\/10.1038\/ajg.2018.27.","journal-title":"Am J Gastroenterol"},{"key":"1636_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ibd\/izy247","volume":"25","author":"SA Hillary","year":"2019","unstructured":"Hillary SA, Remo P, Laura T, Brian B, Reena K, Marshall JK, et al. Clinical practice guideline for the medical management of perianal fistulizing crohn\u2019s disease: the Toronto consensus. Inflamm Bowel Dis. 2019;25:1\u201313. https:\/\/doi.org\/10.1093\/ibd\/izy247.","journal-title":"Inflamm Bowel Dis"},{"key":"1636_CR4","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s00384-014-2104-7","volume":"30","author":"F Cadeddu","year":"2015","unstructured":"Cadeddu F, Salis F, Lisi G, et al. Complex anal fistula remains a challenge for colorectal surgeon. Int J Color Dis. 2015;30:595\u2013603. https:\/\/doi.org\/10.1007\/s00384-014-2104-7.","journal-title":"Int J Color Dis"},{"key":"1636_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse KB, Bemelman W, Kamm MA, et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut. 2014;63:1381\u201392. https:\/\/doi.org\/10.1136\/gutjnl-2013-306709.","journal-title":"Gut"},{"key":"1636_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3748\/wjg.v21.i1.12","volume":"21","author":"E Limura","year":"2015","unstructured":"Limura E, Giordano P. Modern management of anal fistula. World J Gastroenterol. 2015;21:12\u201320. https:\/\/doi.org\/10.3748\/wjg.v21.i1.12.","journal-title":"World J Gastroenterol"},{"key":"1636_CR7","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1007\/s00268-012-1480-9","volume":"36","author":"J Blumetti","year":"2012","unstructured":"Blumetti J, Abcarian A, Quinteros F, et al. Evolution of treatment of fistula in ano. World J Surg. 2012;36:1162\u20137. https:\/\/doi.org\/10.1007\/s00268-012-1480-9.","journal-title":"World J Surg"},{"key":"1636_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3760\/cma.j.issn.1009-2587.2019.09.001","volume":"35","author":"DH Hu","year":"2019","unstructured":"Hu DH, Liu JQ. Application of adipose stem cells in tissue repair and reconstruction. Zhonghua Shao Shang Za Zhi. 2019;35:641\u20134. https:\/\/doi.org\/10.3760\/cma.j.issn.1009-2587.2019.09.001.","journal-title":"Zhonghua Shao Shang Za Zhi"},{"key":"1636_CR9","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1097\/DCR.0000000000000733","volume":"59","author":"JD Vogel","year":"2016","unstructured":"Vogel JD, Johnson EK, Morris AM, et al. Clinical practice guideline for the management of anorectal abscess, fistula-in-ano, and rectovaginal. Dis Colon Rectum. 2016;59:1117\u201333. https:\/\/doi.org\/10.1097\/DCR.0000000000000733.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/BF02052593","volume":"37","author":"YP Sangwan","year":"1994","unstructured":"Sangwan YP, Rosen L, Riether RD, et al. Is simple fistula-in-ano simple. Dis Colon Rectum. 1994;37:885\u20139. https:\/\/doi.org\/10.1007\/BF02052593.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR11","doi-asserted-by":"publisher","first-page":"978","DOI":"10.11569\/wcjd.v24.i6.978","volume":"24","author":"H Chen","year":"2016","unstructured":"Chen H, Leng Q, Jin HY, et al. Current situation of diagnosis and treatment of anal fistula: comparison between china and other countries. World Chin J Digestology. 2016;24:978\u201382. https:\/\/doi.org\/10.11569\/wcjd.v24.i6.978.","journal-title":"World Chin J Digestology"},{"key":"1636_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.surg.2009.05.018","volume":"147","author":"M Adamina","year":"2010","unstructured":"Adamina M, Hoch JS, Burnstein MJ. To plug or not to plug: a cost-effectiveness analysis for complex anal fistula. Surgery. 2010;147:72\u20138. https:\/\/doi.org\/10.1016\/j.surg.2009.05.018.","journal-title":"Surgery"},{"key":"1636_CR13","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1463-1318.2009.01802.x","volume":"12","author":"G El-Gazzaz","year":"2010","unstructured":"El-Gazzaz G, Zutshi M, Hull T. A retrospective review of chronic anal fistulae treated by anal fistulae plug. Color Dis. 2010;12:442\u20137. https:\/\/doi.org\/10.1111\/j.1463-1318.2009.01802.x.","journal-title":"Color Dis"},{"key":"1636_CR14","doi-asserted-by":"publisher","first-page":"A4254","DOI":"10.3109\/13814788.2010.546833","volume":"58","author":"J Kleif","year":"2011","unstructured":"Kleif J. Acceptable results using plug for the treatment of complex anal fistulas. Dan Med Bull. 2011;58:A4254. https:\/\/doi.org\/10.3109\/13814788.2010.546833.","journal-title":"Dan Med Bull"},{"key":"1636_CR15","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/DCR.0b013e31819c96ac","volume":"52","author":"B Safar","year":"2009","unstructured":"Safar B, Jobanputra S, Sands D, et al. Anal fistula plug: initial experience and outcomes. Dis Colon Rectum. 2009;52:248\u201352. https:\/\/doi.org\/10.1007\/DCR.0b013e31819c96ac.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR16","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s10350-004-7247-0","volume":"45","author":"I Lindsey","year":"2002","unstructured":"Lindsey I, Smilgin-Humphreys MM, Cunningham C, et al. A randomized, controlled trial of fibrin glue vs conventional treatment for anal fistula. Dis Colon Rectum. 2002;45:1608\u201315. https:\/\/doi.org\/10.1097\/01.DCR.0000034622.59957.55.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1463-1318.2009.02056.x","volume":"13","author":"DF Altomare","year":"2011","unstructured":"Altomare DF, Greco VJ, Tricomi N, et al. Seton or glue for trans-sphincteric anal fistulae: a prospective randomized crossover clinical trial. Color Dis. 2011;13:82\u20136. https:\/\/doi.org\/10.1111\/j.1463-1318.2009.02056.x.","journal-title":"Color Dis"},{"key":"1636_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/DCR.0b013e31820eee2e","volume":"54","author":"LE Mitalas","year":"2011","unstructured":"Mitalas LE, Dwarkasing RS, Verhaaren R, et al. Is the outcome of transanal advancement flap repair affected by the complexity of high transsphincteric fistulas. Dis Colon Rectum. 2011;54:857\u201362. https:\/\/doi.org\/10.1007\/dcr.0b013e31820eee2e.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR19","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/DCR.0000000000000194","volume":"57","author":"KM Madbouly","year":"2014","unstructured":"Madbouly KM, El Shazly W, Abbas KS, et al. Ligation of intersphincteric fistula tract versus mucosal advancement flap in patients with high transsphincteric fistula-in-ano: a prospective randomized trial. Dis Colon Rectum. 2014;57:1202\u20138. https:\/\/doi.org\/10.1097\/DCR.0000000000000194.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR20","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","volume":"53","author":"A Soltani","year":"2010","unstructured":"Soltani A, Kaiser AM. Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano. Dis Colon Rectum. 2010;53:486\u201395. https:\/\/doi.org\/10.1007\/DCR.0b013e3181ce8b01.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00384-015-2133-x","volume":"30","author":"N Uribe","year":"2015","unstructured":"Uribe N, Balciscueta Z, M\u00ednguez M, et al. \u201cCore out\u201d or \u201ccurettage\u201d in rectal advancement flap for cryptoglandular anal fistula. Int J Color Dis. 2015;30:613\u20139. https:\/\/doi.org\/10.1007\/s00384-015-2133-x.","journal-title":"Int J Color Dis"},{"key":"1636_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/codi.13330","volume":"18","author":"C Kontovounisios","year":"2016","unstructured":"Kontovounisios C, Tekkis P, Tan E, et al. Adoption and success rates of perineal procedures for fistula-in-ano: a systematic review. Color Dis. 2016;18:441\u201358. https:\/\/doi.org\/10.1111\/codi.13330.","journal-title":"Color Dis"},{"key":"1636_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cps.2014.12.007","volume":"42","author":"DM Minteer","year":"2015","unstructured":"Minteer DM, Marra KG, Rubin JP. Adipose stem cells biology, safety, regulation, and regenerative potential. Clin Plast Surg. 2015;42:169\u201379. https:\/\/doi.org\/10.1016\/j.cps.2014.12.007.","journal-title":"Clin Plast Surg"},{"key":"1636_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/ten.tea.2016.0550","volume":"24","author":"J Deng","year":"2018","unstructured":"Deng J, Shi Y, Gao Z, et al. Inhibition of pathological phenotype of hypertrophic scar fibroblasts via coculture with adipose-derived stem cells. Tissue Eng Part A. 2018;24:382\u201393. https:\/\/doi.org\/10.1089\/ten.TEA.2016.0550.","journal-title":"Tissue Eng Part A"},{"key":"1636_CR25","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/stem.2338","volume":"34","author":"X Su","year":"2016","unstructured":"Su X, Lyu Y, Wang W, et al. Fascia origin of adipose cells. Stem Cells. 2016;34:1407\u201319. https:\/\/doi.org\/10.1002\/stem.2338.","journal-title":"Stem Cells"},{"key":"1636_CR26","doi-asserted-by":"publisher","first-page":"169","DOI":"10.15909\/j.cnki.cn61-1347\/r.003344","volume":"29","author":"XW Zhang","year":"2019","unstructured":"Zhang XW, Xu G. Research Progress of adipose stem cells in the treatment of diabetic foot. Med Aesthet Beauty. 2019;29:169\u201374. https:\/\/doi.org\/10.15909\/j.cnki.cn61-1347\/r.003344.","journal-title":"Med Aesthet Beauty"},{"key":"1636_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1055\/s-0033-1343396","volume":"45","author":"DP M\u00fcnch","year":"2013","unstructured":"M\u00fcnch DP. Breast augmentation with autologous fat - experience of 96 procedures with the BEAULI-technique. Handchir Mikrochir Plast Chir. 2013;45:80\u201392. https:\/\/doi.org\/10.1055\/s-0033-1343396.","journal-title":"Handchir Mikrochir Plast Chir"},{"key":"1636_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","volume":"18","author":"D Garc\u00eda-Olmo","year":"2003","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Garc\u00eda LG, et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. Int J Color Dis. 2003;18:451\u20134. https:\/\/doi.org\/10.1007\/s00384-003-0490-3.","journal-title":"Int J Color Dis"},{"key":"1636_CR29","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","volume":"55","author":"MD Herreros","year":"2012","unstructured":"Herreros MD, Garcia-Arranz M, Guadalajara H, et al. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula advanced therapy trial 1) and long-term evaluation. Dis Colon Rectum. 2012;55:762\u201372. https:\/\/doi.org\/10.1097\/DCR.0b013e318255364a.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes J, Garcia-Olmo D, Van Assche G, et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease a phase 3 randomised, double-blind controlled trial. Lancet. 2016;388:1281\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(16)31203-X.","journal-title":"Lancet"},{"key":"1636_CR31","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.3969\/j.issn.2095-4344.0647","volume":"33","author":"L Yan-ni","year":"2018","unstructured":"Yan-ni L, Min N, Rui Z, et al. Treatment of complex anal fistula with adipose-derived stem cells: roles and mechanisms. Chin J Tissue Eng Res. 2018;33:5399. https:\/\/doi.org\/10.3969\/j.issn.2095-4344.0647.","journal-title":"Chin J Tissue Eng Res"},{"key":"1636_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","volume":"154","author":"J Panes","year":"2018","unstructured":"Panes J, Garcia-Olmo D, Van Assche G, et al. Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease. Gastroenterology. 2018;154:1334\u201342. https:\/\/doi.org\/10.1053\/j.gastro.2017.12.020.","journal-title":"Gastroenterology"},{"key":"1636_CR33","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garc\u00eda-Olmo","year":"2005","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D, et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416\u201323. https:\/\/doi.org\/10.1007\/s10350-005-0052-6.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo D, Herreros D, Pascual I, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum. 2009;52:79\u201386. https:\/\/doi.org\/10.1007\/dcr.0b013e3181973487.","journal-title":"Dis Colon Rectum"},{"key":"1636_CR35","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3727\/096368910X508762","volume":"19","author":"H Yagi","year":"2010","unstructured":"Yagi H, Soto-Gutierrez A, Parekkadan B, et al. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 2010;19:667\u201379. https:\/\/doi.org\/10.3727\/096368910X508762.","journal-title":"Cell Transplant"},{"key":"1636_CR36","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.copbio.2012.05.005","volume":"23","author":"O Delarosa","year":"2012","unstructured":"Delarosa O, Dalemans W, Lombardo E. Mesenchymal stem cells as therapeutic agents of inflammatory and autoimmune diseases. Curr Opin Biotechnol. 2012;23:978\u201383. https:\/\/doi.org\/10.1016\/j.copbio.2012.05.005.","journal-title":"Curr Opin Biotechnol"},{"key":"1636_CR37","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s10620-017-4453-x","volume":"62","author":"Y Cao","year":"2017","unstructured":"Cao Y, Ding Z, Han C, et al. Efficacy of mesenchymal stromal cells for fistula treatment of Crohn\u2019s disease: a systematic review and meta-analysis. Dig Dis Sci. 2017;62:851\u201360. https:\/\/doi.org\/10.1007\/s10620-017-4453-x.","journal-title":"Dig Dis Sci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01636-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-01636-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01636-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T20:34:25Z","timestamp":1615926865000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01636-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1636"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01636-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"25 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. All experimental protocols were approved by the ethics committee of Nanjing Hospital of Chinese medicine Affiliated to Nanjing University of Chinese Medicine (Nanjing, China). Written informed consent was obtained from all study subjects or their guardian.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all study subjects and their guardians by signing informed consent form in screening. All the authors consent to publish the paper in Stem Cell Research and Therapy.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}